RenaissThera is designing oral drugs for obesity and type 2 diabetes

Company Details Company Overview Founded 2023 Founders Dr Ramkesh Meena, Sudhir Nagarajan Headquarters Bengaluru Sector Drug discovery, cardio-metabolic disease Funding Raised Seed round from angel investors (December 2024); institutional seed led by Arali Ventures (announced June 2026). Key Investors Arali Ventures (lead) Institutional Support C-CAMP incubation programme (from November 2025) Pipeline Seven small-molecule programmes, all at the discovery stage Obesity drug